nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP3A4—Temozolomide—melanoma	0.207	0.385	CbGbCtD
Bisoprolol—CYP2D6—Vemurafenib—melanoma	0.179	0.332	CbGbCtD
Bisoprolol—CYP3A4—Vemurafenib—melanoma	0.114	0.211	CbGbCtD
Bisoprolol—CYP3A4—Docetaxel—melanoma	0.039	0.0724	CbGbCtD
Bisoprolol—Cardiac failure congestive—Docetaxel—melanoma	0.0011	0.00266	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Temozolomide—melanoma	0.0011	0.00265	CcSEcCtD
Bisoprolol—Alopecia—Bleomycin—melanoma	0.00109	0.00263	CcSEcCtD
Bisoprolol—Sinusitis—Temozolomide—melanoma	0.00109	0.00262	CcSEcCtD
Bisoprolol—Erythema—Bleomycin—melanoma	0.00107	0.00259	CcSEcCtD
Bisoprolol—Hallucination—Carmustine—melanoma	0.00107	0.00259	CcSEcCtD
Bisoprolol—Hypoaesthesia—Carmustine—melanoma	0.00107	0.00259	CcSEcCtD
Bisoprolol—Hot flush—Docetaxel—melanoma	0.00107	0.00258	CcSEcCtD
Bisoprolol—Flushing—Dactinomycin—melanoma	0.00107	0.00258	CcSEcCtD
Bisoprolol—Hypersensitivity—Vemurafenib—melanoma	0.00107	0.00257	CcSEcCtD
Bisoprolol—Oedema peripheral—Carmustine—melanoma	0.00106	0.00256	CcSEcCtD
Bisoprolol—Menopausal symptoms—Docetaxel—melanoma	0.00106	0.00256	CcSEcCtD
Bisoprolol—Connective tissue disorder—Carmustine—melanoma	0.00106	0.00255	CcSEcCtD
Bisoprolol—Atrial fibrillation—Docetaxel—melanoma	0.00106	0.00255	CcSEcCtD
Bisoprolol—Visual disturbance—Docetaxel—melanoma	0.00106	0.00255	CcSEcCtD
Bisoprolol—Hepatitis—Temozolomide—melanoma	0.00104	0.00251	CcSEcCtD
Bisoprolol—Asthenia—Vemurafenib—melanoma	0.00104	0.0025	CcSEcCtD
Bisoprolol—Visual impairment—Carmustine—melanoma	0.00104	0.0025	CcSEcCtD
Bisoprolol—Hallucination—Temozolomide—melanoma	0.00104	0.0025	CcSEcCtD
Bisoprolol—Hypoaesthesia—Temozolomide—melanoma	0.00104	0.0025	CcSEcCtD
Bisoprolol—Pharyngitis—Temozolomide—melanoma	0.00103	0.00249	CcSEcCtD
Bisoprolol—Oedema peripheral—Temozolomide—melanoma	0.00103	0.00247	CcSEcCtD
Bisoprolol—Cardiac failure—Docetaxel—melanoma	0.00103	0.00247	CcSEcCtD
Bisoprolol—Pruritus—Vemurafenib—melanoma	0.00102	0.00247	CcSEcCtD
Bisoprolol—Connective tissue disorder—Temozolomide—melanoma	0.00102	0.00247	CcSEcCtD
Bisoprolol—Alopecia—Dactinomycin—melanoma	0.00102	0.00245	CcSEcCtD
Bisoprolol—Eye disorder—Carmustine—melanoma	0.00101	0.00243	CcSEcCtD
Bisoprolol—Visual impairment—Temozolomide—melanoma	0.001	0.00242	CcSEcCtD
Bisoprolol—Erythema—Dactinomycin—melanoma	0.001	0.00242	CcSEcCtD
Bisoprolol—Flushing—Carmustine—melanoma	0.001	0.00241	CcSEcCtD
Bisoprolol—Ill-defined disorder—Bleomycin—melanoma	0.000997	0.0024	CcSEcCtD
Bisoprolol—Diarrhoea—Vemurafenib—melanoma	0.000991	0.00239	CcSEcCtD
Bisoprolol—Eye disorder—Temozolomide—melanoma	0.000973	0.00235	CcSEcCtD
Bisoprolol—Tinnitus—Temozolomide—melanoma	0.000971	0.00234	CcSEcCtD
Bisoprolol—Malaise—Bleomycin—melanoma	0.000969	0.00234	CcSEcCtD
Bisoprolol—Flushing—Temozolomide—melanoma	0.000967	0.00233	CcSEcCtD
Bisoprolol—Cardiac disorder—Temozolomide—melanoma	0.000967	0.00233	CcSEcCtD
Bisoprolol—Arrhythmia—Carmustine—melanoma	0.000963	0.00232	CcSEcCtD
Bisoprolol—Dizziness—Vemurafenib—melanoma	0.000957	0.00231	CcSEcCtD
Bisoprolol—Alopecia—Carmustine—melanoma	0.000952	0.0023	CcSEcCtD
Bisoprolol—Angiopathy—Temozolomide—melanoma	0.000945	0.00228	CcSEcCtD
Bisoprolol—Mental disorder—Carmustine—melanoma	0.000944	0.00228	CcSEcCtD
Bisoprolol—Mediastinal disorder—Temozolomide—melanoma	0.000939	0.00226	CcSEcCtD
Bisoprolol—Erythema—Carmustine—melanoma	0.000938	0.00226	CcSEcCtD
Bisoprolol—Cough—Bleomycin—melanoma	0.000938	0.00226	CcSEcCtD
Bisoprolol—Ill-defined disorder—Dactinomycin—melanoma	0.00093	0.00224	CcSEcCtD
Bisoprolol—Vomiting—Vemurafenib—melanoma	0.000921	0.00222	CcSEcCtD
Bisoprolol—Alopecia—Temozolomide—melanoma	0.00092	0.00222	CcSEcCtD
Bisoprolol—Chest pain—Bleomycin—melanoma	0.000915	0.00221	CcSEcCtD
Bisoprolol—Myalgia—Bleomycin—melanoma	0.000915	0.00221	CcSEcCtD
Bisoprolol—Abdominal pain upper—Docetaxel—melanoma	0.000914	0.0022	CcSEcCtD
Bisoprolol—Orthostatic hypotension—Docetaxel—melanoma	0.000914	0.0022	CcSEcCtD
Bisoprolol—Rash—Vemurafenib—melanoma	0.000913	0.0022	CcSEcCtD
Bisoprolol—Mental disorder—Temozolomide—melanoma	0.000912	0.0022	CcSEcCtD
Bisoprolol—Dermatitis—Vemurafenib—melanoma	0.000912	0.0022	CcSEcCtD
Bisoprolol—Back pain—Carmustine—melanoma	0.000908	0.00219	CcSEcCtD
Bisoprolol—Headache—Vemurafenib—melanoma	0.000907	0.00219	CcSEcCtD
Bisoprolol—Erythema—Temozolomide—melanoma	0.000907	0.00219	CcSEcCtD
Bisoprolol—Breast disorder—Docetaxel—melanoma	0.000905	0.00218	CcSEcCtD
Bisoprolol—Discomfort—Bleomycin—melanoma	0.000904	0.00218	CcSEcCtD
Bisoprolol—Malaise—Dactinomycin—melanoma	0.000904	0.00218	CcSEcCtD
Bisoprolol—Cramp muscle—Docetaxel—melanoma	0.000902	0.00217	CcSEcCtD
Bisoprolol—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000902	0.00217	CcSEcCtD
Bisoprolol—Dysgeusia—Temozolomide—melanoma	0.000888	0.00214	CcSEcCtD
Bisoprolol—Confusional state—Bleomycin—melanoma	0.000884	0.00213	CcSEcCtD
Bisoprolol—Tremor—Carmustine—melanoma	0.000879	0.00212	CcSEcCtD
Bisoprolol—Oedema—Bleomycin—melanoma	0.000877	0.00211	CcSEcCtD
Bisoprolol—Back pain—Temozolomide—melanoma	0.000877	0.00211	CcSEcCtD
Bisoprolol—Infection—Bleomycin—melanoma	0.000871	0.0021	CcSEcCtD
Bisoprolol—Agitation—Carmustine—melanoma	0.000862	0.00208	CcSEcCtD
Bisoprolol—Nausea—Vemurafenib—melanoma	0.00086	0.00207	CcSEcCtD
Bisoprolol—Thrombocytopenia—Bleomycin—melanoma	0.000859	0.00207	CcSEcCtD
Bisoprolol—Myalgia—Dactinomycin—melanoma	0.000853	0.00206	CcSEcCtD
Bisoprolol—Bronchospasm—Docetaxel—melanoma	0.000851	0.00205	CcSEcCtD
Bisoprolol—Tremor—Temozolomide—melanoma	0.000849	0.00205	CcSEcCtD
Bisoprolol—Discomfort—Dactinomycin—melanoma	0.000843	0.00203	CcSEcCtD
Bisoprolol—Ill-defined disorder—Temozolomide—melanoma	0.000841	0.00203	CcSEcCtD
Bisoprolol—Agitation—Temozolomide—melanoma	0.000833	0.00201	CcSEcCtD
Bisoprolol—Angioedema—Temozolomide—melanoma	0.000828	0.002	CcSEcCtD
Bisoprolol—Hypotension—Bleomycin—melanoma	0.00082	0.00198	CcSEcCtD
Bisoprolol—Oedema—Dactinomycin—melanoma	0.000818	0.00197	CcSEcCtD
Bisoprolol—Malaise—Temozolomide—melanoma	0.000818	0.00197	CcSEcCtD
Bisoprolol—Vertigo—Temozolomide—melanoma	0.000815	0.00196	CcSEcCtD
Bisoprolol—Infection—Dactinomycin—melanoma	0.000813	0.00196	CcSEcCtD
Bisoprolol—Palpitations—Temozolomide—melanoma	0.000801	0.00193	CcSEcCtD
Bisoprolol—Thrombocytopenia—Dactinomycin—melanoma	0.000801	0.00193	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Bleomycin—melanoma	0.000799	0.00193	CcSEcCtD
Bisoprolol—Chest pain—Carmustine—melanoma	0.000799	0.00193	CcSEcCtD
Bisoprolol—Myalgia—Carmustine—melanoma	0.000799	0.00193	CcSEcCtD
Bisoprolol—Anxiety—Carmustine—melanoma	0.000796	0.00192	CcSEcCtD
Bisoprolol—Cough—Temozolomide—melanoma	0.000791	0.00191	CcSEcCtD
Bisoprolol—Paraesthesia—Bleomycin—melanoma	0.000788	0.0019	CcSEcCtD
Bisoprolol—Weight increased—Docetaxel—melanoma	0.000787	0.0019	CcSEcCtD
Bisoprolol—Dyspnoea—Bleomycin—melanoma	0.000782	0.00189	CcSEcCtD
Bisoprolol—Pneumonia—Docetaxel—melanoma	0.000776	0.00187	CcSEcCtD
Bisoprolol—Confusional state—Carmustine—melanoma	0.000772	0.00186	CcSEcCtD
Bisoprolol—Myalgia—Temozolomide—melanoma	0.000772	0.00186	CcSEcCtD
Bisoprolol—Arthralgia—Temozolomide—melanoma	0.000772	0.00186	CcSEcCtD
Bisoprolol—Anxiety—Temozolomide—melanoma	0.000769	0.00185	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000767	0.00185	CcSEcCtD
Bisoprolol—Oedema—Carmustine—melanoma	0.000766	0.00185	CcSEcCtD
Bisoprolol—Discomfort—Temozolomide—melanoma	0.000763	0.00184	CcSEcCtD
Bisoprolol—Infection—Carmustine—melanoma	0.000761	0.00183	CcSEcCtD
Bisoprolol—Acute coronary syndrome—Docetaxel—melanoma	0.000761	0.00183	CcSEcCtD
Bisoprolol—Myocardial infarction—Docetaxel—melanoma	0.000756	0.00182	CcSEcCtD
Bisoprolol—Dry mouth—Temozolomide—melanoma	0.000755	0.00182	CcSEcCtD
Bisoprolol—Pain—Bleomycin—melanoma	0.00075	0.00181	CcSEcCtD
Bisoprolol—Conjunctivitis—Docetaxel—melanoma	0.00075	0.00181	CcSEcCtD
Bisoprolol—Thrombocytopenia—Carmustine—melanoma	0.00075	0.00181	CcSEcCtD
Bisoprolol—Tachycardia—Carmustine—melanoma	0.000747	0.0018	CcSEcCtD
Bisoprolol—Confusional state—Temozolomide—melanoma	0.000746	0.0018	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000745	0.0018	CcSEcCtD
Bisoprolol—Oedema—Temozolomide—melanoma	0.00074	0.00178	CcSEcCtD
Bisoprolol—Infection—Temozolomide—melanoma	0.000735	0.00177	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Docetaxel—melanoma	0.00073	0.00176	CcSEcCtD
Bisoprolol—Nervous system disorder—Temozolomide—melanoma	0.000726	0.00175	CcSEcCtD
Bisoprolol—Thrombocytopenia—Temozolomide—melanoma	0.000724	0.00175	CcSEcCtD
Bisoprolol—Feeling abnormal—Bleomycin—melanoma	0.000723	0.00174	CcSEcCtD
Bisoprolol—Agranulocytosis—Docetaxel—melanoma	0.00072	0.00174	CcSEcCtD
Bisoprolol—Skin disorder—Temozolomide—melanoma	0.000719	0.00173	CcSEcCtD
Bisoprolol—Hypotension—Carmustine—melanoma	0.000715	0.00173	CcSEcCtD
Bisoprolol—Hyperhidrosis—Temozolomide—melanoma	0.000715	0.00172	CcSEcCtD
Bisoprolol—Fatigue—Dactinomycin—melanoma	0.000705	0.0017	CcSEcCtD
Bisoprolol—Pain—Dactinomycin—melanoma	0.0007	0.00169	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Carmustine—melanoma	0.000698	0.00168	CcSEcCtD
Bisoprolol—Urticaria—Bleomycin—melanoma	0.000697	0.00168	CcSEcCtD
Bisoprolol—Rhinitis—Docetaxel—melanoma	0.000694	0.00167	CcSEcCtD
Bisoprolol—Body temperature increased—Bleomycin—melanoma	0.000693	0.00167	CcSEcCtD
Bisoprolol—Hepatitis—Docetaxel—melanoma	0.000693	0.00167	CcSEcCtD
Bisoprolol—Insomnia—Carmustine—melanoma	0.000693	0.00167	CcSEcCtD
Bisoprolol—Hypoaesthesia—Docetaxel—melanoma	0.000689	0.00166	CcSEcCtD
Bisoprolol—Paraesthesia—Carmustine—melanoma	0.000688	0.00166	CcSEcCtD
Bisoprolol—Pharyngitis—Docetaxel—melanoma	0.000687	0.00166	CcSEcCtD
Bisoprolol—Dyspnoea—Carmustine—melanoma	0.000683	0.00165	CcSEcCtD
Bisoprolol—Oedema peripheral—Docetaxel—melanoma	0.000682	0.00165	CcSEcCtD
Bisoprolol—Somnolence—Carmustine—melanoma	0.000681	0.00164	CcSEcCtD
Bisoprolol—Connective tissue disorder—Docetaxel—melanoma	0.000681	0.00164	CcSEcCtD
Bisoprolol—Feeling abnormal—Dactinomycin—melanoma	0.000674	0.00163	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Temozolomide—melanoma	0.000674	0.00163	CcSEcCtD
Bisoprolol—Insomnia—Temozolomide—melanoma	0.000669	0.00161	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Dactinomycin—melanoma	0.000669	0.00161	CcSEcCtD
Bisoprolol—Visual impairment—Docetaxel—melanoma	0.000667	0.00161	CcSEcCtD
Bisoprolol—Paraesthesia—Temozolomide—melanoma	0.000664	0.0016	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Carmustine—melanoma	0.000661	0.00159	CcSEcCtD
Bisoprolol—Dyspnoea—Temozolomide—melanoma	0.00066	0.00159	CcSEcCtD
Bisoprolol—Somnolence—Temozolomide—melanoma	0.000658	0.00159	CcSEcCtD
Bisoprolol—Constipation—Carmustine—melanoma	0.000655	0.00158	CcSEcCtD
Bisoprolol—Pain—Carmustine—melanoma	0.000655	0.00158	CcSEcCtD
Bisoprolol—Dyspepsia—Temozolomide—melanoma	0.000651	0.00157	CcSEcCtD
Bisoprolol—Eye disorder—Docetaxel—melanoma	0.000647	0.00156	CcSEcCtD
Bisoprolol—Abdominal pain—Dactinomycin—melanoma	0.000647	0.00156	CcSEcCtD
Bisoprolol—Body temperature increased—Dactinomycin—melanoma	0.000647	0.00156	CcSEcCtD
Bisoprolol—Hypersensitivity—Bleomycin—melanoma	0.000646	0.00156	CcSEcCtD
Bisoprolol—Flushing—Docetaxel—melanoma	0.000643	0.00155	CcSEcCtD
Bisoprolol—Cardiac disorder—Docetaxel—melanoma	0.000643	0.00155	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Temozolomide—melanoma	0.000639	0.00154	CcSEcCtD
Bisoprolol—Fatigue—Temozolomide—melanoma	0.000638	0.00154	CcSEcCtD
Bisoprolol—Pain—Temozolomide—melanoma	0.000633	0.00153	CcSEcCtD
Bisoprolol—Constipation—Temozolomide—melanoma	0.000633	0.00153	CcSEcCtD
Bisoprolol—Feeling abnormal—Carmustine—melanoma	0.000631	0.00152	CcSEcCtD
Bisoprolol—Asthenia—Bleomycin—melanoma	0.000629	0.00152	CcSEcCtD
Bisoprolol—Angiopathy—Docetaxel—melanoma	0.000628	0.00152	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Carmustine—melanoma	0.000626	0.00151	CcSEcCtD
Bisoprolol—Mediastinal disorder—Docetaxel—melanoma	0.000624	0.0015	CcSEcCtD
Bisoprolol—Pruritus—Bleomycin—melanoma	0.000621	0.0015	CcSEcCtD
Bisoprolol—Arrhythmia—Docetaxel—melanoma	0.000619	0.00149	CcSEcCtD
Bisoprolol—Alopecia—Docetaxel—melanoma	0.000612	0.00148	CcSEcCtD
Bisoprolol—Feeling abnormal—Temozolomide—melanoma	0.00061	0.00147	CcSEcCtD
Bisoprolol—Mental disorder—Docetaxel—melanoma	0.000607	0.00146	CcSEcCtD
Bisoprolol—Abdominal pain—Carmustine—melanoma	0.000605	0.00146	CcSEcCtD
Bisoprolol—Body temperature increased—Carmustine—melanoma	0.000605	0.00146	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Temozolomide—melanoma	0.000605	0.00146	CcSEcCtD
Bisoprolol—Erythema—Docetaxel—melanoma	0.000603	0.00145	CcSEcCtD
Bisoprolol—Hypersensitivity—Dactinomycin—melanoma	0.000603	0.00145	CcSEcCtD
Bisoprolol—Dysgeusia—Docetaxel—melanoma	0.00059	0.00142	CcSEcCtD
Bisoprolol—Chlorphenesin—PTGS2—melanoma	0.000589	0.275	CrCbGaD
Bisoprolol—Urticaria—Temozolomide—melanoma	0.000588	0.00142	CcSEcCtD
Bisoprolol—Asthenia—Dactinomycin—melanoma	0.000587	0.00142	CcSEcCtD
Bisoprolol—Body temperature increased—Temozolomide—melanoma	0.000585	0.00141	CcSEcCtD
Bisoprolol—Abdominal pain—Temozolomide—melanoma	0.000585	0.00141	CcSEcCtD
Bisoprolol—Back pain—Docetaxel—melanoma	0.000583	0.00141	CcSEcCtD
Bisoprolol—Muscle spasms—Docetaxel—melanoma	0.00058	0.0014	CcSEcCtD
Bisoprolol—Hypersensitivity—Carmustine—melanoma	0.000564	0.00136	CcSEcCtD
Bisoprolol—Diarrhoea—Dactinomycin—melanoma	0.00056	0.00135	CcSEcCtD
Bisoprolol—Vomiting—Bleomycin—melanoma	0.000558	0.00134	CcSEcCtD
Bisoprolol—Rash—Bleomycin—melanoma	0.000553	0.00133	CcSEcCtD
Bisoprolol—Dermatitis—Bleomycin—melanoma	0.000553	0.00133	CcSEcCtD
Bisoprolol—Asthenia—Carmustine—melanoma	0.000549	0.00132	CcSEcCtD
Bisoprolol—Hypersensitivity—Temozolomide—melanoma	0.000545	0.00131	CcSEcCtD
Bisoprolol—Syncope—Docetaxel—melanoma	0.000541	0.0013	CcSEcCtD
Bisoprolol—Palpitations—Docetaxel—melanoma	0.000533	0.00128	CcSEcCtD
Bisoprolol—Asthenia—Temozolomide—melanoma	0.000531	0.00128	CcSEcCtD
Bisoprolol—Loss of consciousness—Docetaxel—melanoma	0.00053	0.00128	CcSEcCtD
Bisoprolol—Cough—Docetaxel—melanoma	0.000526	0.00127	CcSEcCtD
Bisoprolol—Diarrhoea—Carmustine—melanoma	0.000524	0.00126	CcSEcCtD
Bisoprolol—Pruritus—Temozolomide—melanoma	0.000524	0.00126	CcSEcCtD
Bisoprolol—Nausea—Bleomycin—melanoma	0.000521	0.00126	CcSEcCtD
Bisoprolol—Vomiting—Dactinomycin—melanoma	0.00052	0.00125	CcSEcCtD
Bisoprolol—Rash—Dactinomycin—melanoma	0.000516	0.00124	CcSEcCtD
Bisoprolol—Chest pain—Docetaxel—melanoma	0.000513	0.00124	CcSEcCtD
Bisoprolol—Myalgia—Docetaxel—melanoma	0.000513	0.00124	CcSEcCtD
Bisoprolol—Arthralgia—Docetaxel—melanoma	0.000513	0.00124	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00051	0.00123	CcSEcCtD
Bisoprolol—Dizziness—Carmustine—melanoma	0.000506	0.00122	CcSEcCtD
Bisoprolol—Diarrhoea—Temozolomide—melanoma	0.000506	0.00122	CcSEcCtD
Bisoprolol—Dry mouth—Docetaxel—melanoma	0.000502	0.00121	CcSEcCtD
Bisoprolol—Atenolol—ABCB1—melanoma	0.000501	0.234	CrCbGaD
Bisoprolol—Confusional state—Docetaxel—melanoma	0.000496	0.0012	CcSEcCtD
Bisoprolol—Oedema—Docetaxel—melanoma	0.000492	0.00119	CcSEcCtD
Bisoprolol—Dizziness—Temozolomide—melanoma	0.000489	0.00118	CcSEcCtD
Bisoprolol—Infection—Docetaxel—melanoma	0.000489	0.00118	CcSEcCtD
Bisoprolol—Vomiting—Carmustine—melanoma	0.000487	0.00117	CcSEcCtD
Bisoprolol—Nausea—Dactinomycin—melanoma	0.000486	0.00117	CcSEcCtD
Bisoprolol—Shock—Docetaxel—melanoma	0.000484	0.00117	CcSEcCtD
Bisoprolol—Rash—Carmustine—melanoma	0.000483	0.00116	CcSEcCtD
Bisoprolol—Nervous system disorder—Docetaxel—melanoma	0.000483	0.00116	CcSEcCtD
Bisoprolol—Dermatitis—Carmustine—melanoma	0.000482	0.00116	CcSEcCtD
Bisoprolol—Thrombocytopenia—Docetaxel—melanoma	0.000482	0.00116	CcSEcCtD
Bisoprolol—Tachycardia—Docetaxel—melanoma	0.00048	0.00116	CcSEcCtD
Bisoprolol—Headache—Carmustine—melanoma	0.00048	0.00116	CcSEcCtD
Bisoprolol—Skin disorder—Docetaxel—melanoma	0.000478	0.00115	CcSEcCtD
Bisoprolol—Vomiting—Temozolomide—melanoma	0.00047	0.00113	CcSEcCtD
Bisoprolol—Rash—Temozolomide—melanoma	0.000467	0.00112	CcSEcCtD
Bisoprolol—Dermatitis—Temozolomide—melanoma	0.000466	0.00112	CcSEcCtD
Bisoprolol—Headache—Temozolomide—melanoma	0.000464	0.00112	CcSEcCtD
Bisoprolol—Acebutolol—ABCB1—melanoma	0.000462	0.216	CrCbGaD
Bisoprolol—Hypotension—Docetaxel—melanoma	0.00046	0.00111	CcSEcCtD
Bisoprolol—Nausea—Carmustine—melanoma	0.000455	0.0011	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Docetaxel—melanoma	0.000448	0.00108	CcSEcCtD
Bisoprolol—Insomnia—Docetaxel—melanoma	0.000445	0.00107	CcSEcCtD
Bisoprolol—Paraesthesia—Docetaxel—melanoma	0.000442	0.00107	CcSEcCtD
Bisoprolol—Nausea—Temozolomide—melanoma	0.00044	0.00106	CcSEcCtD
Bisoprolol—Dyspnoea—Docetaxel—melanoma	0.000439	0.00106	CcSEcCtD
Bisoprolol—Somnolence—Docetaxel—melanoma	0.000437	0.00105	CcSEcCtD
Bisoprolol—Dyspepsia—Docetaxel—melanoma	0.000433	0.00104	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Docetaxel—melanoma	0.000425	0.00102	CcSEcCtD
Bisoprolol—Fatigue—Docetaxel—melanoma	0.000424	0.00102	CcSEcCtD
Bisoprolol—Pain—Docetaxel—melanoma	0.000421	0.00101	CcSEcCtD
Bisoprolol—Constipation—Docetaxel—melanoma	0.000421	0.00101	CcSEcCtD
Bisoprolol—Feeling abnormal—Docetaxel—melanoma	0.000405	0.000978	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Docetaxel—melanoma	0.000402	0.00097	CcSEcCtD
Bisoprolol—Metoprolol—ABCB1—melanoma	0.00039	0.182	CrCbGaD
Bisoprolol—Abdominal pain—Docetaxel—melanoma	0.000389	0.000938	CcSEcCtD
Bisoprolol—Body temperature increased—Docetaxel—melanoma	0.000389	0.000938	CcSEcCtD
Bisoprolol—Hypersensitivity—Docetaxel—melanoma	0.000363	0.000874	CcSEcCtD
Bisoprolol—Asthenia—Docetaxel—melanoma	0.000353	0.000851	CcSEcCtD
Bisoprolol—Pruritus—Docetaxel—melanoma	0.000348	0.000839	CcSEcCtD
Bisoprolol—Diarrhoea—Docetaxel—melanoma	0.000337	0.000812	CcSEcCtD
Bisoprolol—Dizziness—Docetaxel—melanoma	0.000325	0.000785	CcSEcCtD
Bisoprolol—Vomiting—Docetaxel—melanoma	0.000313	0.000754	CcSEcCtD
Bisoprolol—Rash—Docetaxel—melanoma	0.00031	0.000748	CcSEcCtD
Bisoprolol—Dermatitis—Docetaxel—melanoma	0.00031	0.000747	CcSEcCtD
Bisoprolol—Headache—Docetaxel—melanoma	0.000308	0.000743	CcSEcCtD
Bisoprolol—Nausea—Docetaxel—melanoma	0.000292	0.000705	CcSEcCtD
Bisoprolol—Propranolol—ABCB1—melanoma	0.000197	0.092	CrCbGaD
Bisoprolol—ADRB1—Signaling by GPCR—MAP2K2—melanoma	2.71e-05	0.000605	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—MAP2K2—melanoma	2.65e-05	0.000592	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—F2R—melanoma	2.65e-05	0.000592	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—F2R—melanoma	2.59e-05	0.000579	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PHGDH—melanoma	2.59e-05	0.000579	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—LUM—melanoma	2.59e-05	0.000579	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—RAC1—melanoma	2.57e-05	0.000574	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EDNRB—melanoma	2.56e-05	0.000573	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HPSE—melanoma	2.54e-05	0.000568	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—RAC1—melanoma	2.51e-05	0.000561	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EDNRB—melanoma	2.51e-05	0.000561	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CUBN—melanoma	2.49e-05	0.000557	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PTK2B—melanoma	2.49e-05	0.000556	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PTK2B—melanoma	2.43e-05	0.000544	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GAB2—melanoma	2.42e-05	0.000541	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GNA11—melanoma	2.42e-05	0.000541	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FLT1—melanoma	2.41e-05	0.000539	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—BSG—melanoma	2.41e-05	0.000538	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SDHD—melanoma	2.41e-05	0.000538	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CSPG4—melanoma	2.41e-05	0.000538	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PIK3CG—melanoma	2.39e-05	0.000534	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GAB2—melanoma	2.37e-05	0.000529	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GNA11—melanoma	2.37e-05	0.000529	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FLT1—melanoma	2.36e-05	0.000527	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PIK3CG—melanoma	2.34e-05	0.000522	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GPAM—melanoma	2.33e-05	0.000521	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FOXO4—melanoma	2.28e-05	0.000509	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HDAC2—melanoma	2.28e-05	0.000509	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CXCR4—melanoma	2.28e-05	0.000509	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GNAQ—melanoma	2.25e-05	0.000503	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HDAC2—melanoma	2.23e-05	0.000498	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FOXO4—melanoma	2.23e-05	0.000498	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CXCR4—melanoma	2.23e-05	0.000498	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GNAQ—melanoma	2.2e-05	0.000492	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PIK3CG—melanoma	2.17e-05	0.000485	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PIK3CG—melanoma	2.12e-05	0.000474	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SYK—melanoma	2.12e-05	0.000473	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PIK3CD—melanoma	2.1e-05	0.000469	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AKT3—melanoma	2.08e-05	0.000464	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ITGAV—melanoma	2.08e-05	0.000464	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NGFR—melanoma	2.08e-05	0.000464	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PLCB4—melanoma	2.08e-05	0.000464	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SYK—melanoma	2.07e-05	0.000463	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PIK3CD—melanoma	2.05e-05	0.000459	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ITGAV—melanoma	2.03e-05	0.000454	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NGFR—melanoma	2.03e-05	0.000454	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AKT3—melanoma	2.03e-05	0.000454	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PLA2G6—melanoma	1.98e-05	0.000443	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SLC6A11—melanoma	1.95e-05	0.000436	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PIP4K2A—melanoma	1.95e-05	0.000436	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SOCS1—melanoma	1.92e-05	0.00043	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—MAP2K1—melanoma	1.92e-05	0.000429	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—S100B—melanoma	1.92e-05	0.000429	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PIK3CD—melanoma	1.91e-05	0.000426	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MTAP—melanoma	1.9e-05	0.000425	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SOCS1—melanoma	1.88e-05	0.000421	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—MAP2K1—melanoma	1.88e-05	0.00042	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—S100B—melanoma	1.88e-05	0.00042	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PIK3CD—melanoma	1.86e-05	0.000417	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ERBB4—melanoma	1.83e-05	0.00041	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	1.83e-05	0.000409	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CDKN2B—melanoma	1.82e-05	0.000407	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ERBB4—melanoma	1.79e-05	0.000401	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	1.79e-05	0.0004	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—VCAN—melanoma	1.78e-05	0.000398	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CDKN2B—melanoma	1.78e-05	0.000398	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CD86—melanoma	1.76e-05	0.000393	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—CXCL8—melanoma	1.76e-05	0.000393	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EDN1—melanoma	1.75e-05	0.00039	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CD86—melanoma	1.72e-05	0.000385	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	1.72e-05	0.000385	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EDN1—melanoma	1.71e-05	0.000382	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CSF2—melanoma	1.71e-05	0.000381	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FGF1—melanoma	1.71e-05	0.000381	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LUM—melanoma	1.69e-05	0.000378	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PHGDH—melanoma	1.69e-05	0.000378	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—IL2—melanoma	1.68e-05	0.000376	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—E2F1—melanoma	1.67e-05	0.000373	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CSF2—melanoma	1.67e-05	0.000373	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FGF1—melanoma	1.67e-05	0.000373	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	1.66e-05	0.000371	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HPSE—melanoma	1.66e-05	0.000371	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PDGFRA—melanoma	1.65e-05	0.000369	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—IL2—melanoma	1.64e-05	0.000367	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ITGB3—melanoma	1.64e-05	0.000366	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PRKCA—melanoma	1.64e-05	0.000366	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—E2F1—melanoma	1.63e-05	0.000365	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CUBN—melanoma	1.63e-05	0.000364	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	1.63e-05	0.000363	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PDGFRA—melanoma	1.62e-05	0.000361	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SPP1—melanoma	1.6e-05	0.000359	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PRKCA—melanoma	1.6e-05	0.000358	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ITGB3—melanoma	1.6e-05	0.000358	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAP2K2—melanoma	1.6e-05	0.000357	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CXCL8—melanoma	1.6e-05	0.000357	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SDHD—melanoma	1.57e-05	0.000352	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CSPG4—melanoma	1.57e-05	0.000352	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—BSG—melanoma	1.57e-05	0.000352	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SPP1—melanoma	1.57e-05	0.000351	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAP2K2—melanoma	1.56e-05	0.00035	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CXCL8—melanoma	1.56e-05	0.000349	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL2—melanoma	1.53e-05	0.000341	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GPAM—melanoma	1.52e-05	0.000341	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TERT—melanoma	1.52e-05	0.00034	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RAC1—melanoma	1.52e-05	0.000339	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP17A1—melanoma	1.5e-05	0.000336	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL2—melanoma	1.49e-05	0.000334	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TERT—melanoma	1.49e-05	0.000332	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RAC1—melanoma	1.48e-05	0.000332	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HIF1A—melanoma	1.45e-05	0.000325	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HIF1A—melanoma	1.42e-05	0.000318	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GNA11—melanoma	1.42e-05	0.000317	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—KDR—melanoma	1.39e-05	0.000311	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—FASN—melanoma	1.39e-05	0.00031	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SLC5A5—melanoma	1.37e-05	0.000305	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—KDR—melanoma	1.36e-05	0.000304	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FN1—melanoma	1.34e-05	0.000299	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GNAQ—melanoma	1.32e-05	0.000295	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CD44—melanoma	1.32e-05	0.000295	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NOTCH1—melanoma	1.31e-05	0.000293	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FN1—melanoma	1.31e-05	0.000293	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PLA2G6—melanoma	1.3e-05	0.00029	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CD80—melanoma	1.28e-05	0.000287	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NOTCH1—melanoma	1.28e-05	0.000286	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—KIT—melanoma	1.28e-05	0.000286	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APC—melanoma	1.28e-05	0.000286	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PIK3CG—melanoma	1.28e-05	0.000286	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—NRAS—melanoma	1.28e-05	0.000286	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EGF—melanoma	1.27e-05	0.000283	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP1B1—melanoma	1.26e-05	0.000283	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CD80—melanoma	1.26e-05	0.000281	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APC—melanoma	1.25e-05	0.00028	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PIK3CG—melanoma	1.25e-05	0.00028	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—KIT—melanoma	1.25e-05	0.00028	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—NRAS—melanoma	1.25e-05	0.00028	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EGF—melanoma	1.24e-05	0.000277	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—MAPK3—melanoma	1.23e-05	0.000274	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—BRAF—melanoma	1.2e-05	0.000269	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—MAPK3—melanoma	1.2e-05	0.000268	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—BRAF—melanoma	1.18e-05	0.000263	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IGF1—melanoma	1.17e-05	0.000262	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—MAPK1—melanoma	1.17e-05	0.000261	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—EGFR—melanoma	1.17e-05	0.000261	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—VCAN—melanoma	1.16e-05	0.00026	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IGF1—melanoma	1.15e-05	0.000256	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—MAPK1—melanoma	1.14e-05	0.000255	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—EGFR—melanoma	1.14e-05	0.000255	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAP2K1—melanoma	1.13e-05	0.000253	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PIK3CD—melanoma	1.13e-05	0.000252	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	1.12e-05	0.000249	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAP2K1—melanoma	1.11e-05	0.000248	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—KRAS—melanoma	1.1e-05	0.000246	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PIK3CD—melanoma	1.1e-05	0.000246	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	1.09e-05	0.000244	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—KRAS—melanoma	1.08e-05	0.000241	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FGF2—melanoma	1.08e-05	0.000241	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FGF2—melanoma	1.05e-05	0.000236	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ABCB1—melanoma	1.04e-05	0.000233	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	1.01e-05	0.000226	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MDM2—melanoma	1.01e-05	0.000226	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ERBB2—melanoma	9.95e-06	0.000222	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	9.91e-06	0.000222	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MDM2—melanoma	9.87e-06	0.000221	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP17A1—melanoma	9.82e-06	0.00022	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PIK3CB—melanoma	9.82e-06	0.000219	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ERBB2—melanoma	9.73e-06	0.000218	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PIK3CB—melanoma	9.6e-06	0.000215	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PRKCA—melanoma	9.58e-06	0.000214	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ERCC2—melanoma	9.5e-06	0.000212	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CXCL8—melanoma	9.43e-06	0.000211	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HRAS—melanoma	9.37e-06	0.000209	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GNA11—melanoma	9.27e-06	0.000207	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CXCL8—melanoma	9.23e-06	0.000206	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CDKN1B—melanoma	9.21e-06	0.000206	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HRAS—melanoma	9.17e-06	0.000205	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—AKT1—melanoma	9.11e-06	0.000204	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—FASN—melanoma	9.07e-06	0.000203	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CASP3—melanoma	9.03e-06	0.000202	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL2—melanoma	9.01e-06	0.000202	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CDKN1B—melanoma	9.01e-06	0.000201	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL6—melanoma	8.97e-06	0.000201	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SLC5A5—melanoma	8.93e-06	0.0002	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—AKT1—melanoma	8.91e-06	0.000199	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CASP3—melanoma	8.83e-06	0.000197	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL2—melanoma	8.82e-06	0.000197	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCND1—melanoma	8.79e-06	0.000196	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL6—melanoma	8.77e-06	0.000196	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CTNNB1—melanoma	8.7e-06	0.000195	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GNAQ—melanoma	8.62e-06	0.000193	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CD44—melanoma	8.62e-06	0.000193	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCND1—melanoma	8.6e-06	0.000192	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MMP9—melanoma	8.53e-06	0.000191	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CTNNB1—melanoma	8.51e-06	0.00019	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CDKN1A—melanoma	8.5e-06	0.00019	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PTEN—melanoma	8.48e-06	0.00019	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NFKB1—melanoma	8.44e-06	0.000189	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MMP9—melanoma	8.35e-06	0.000187	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CDKN1A—melanoma	8.32e-06	0.000186	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PTEN—melanoma	8.3e-06	0.000185	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—AKT1—melanoma	8.27e-06	0.000185	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP1B1—melanoma	8.27e-06	0.000185	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NFKB1—melanoma	8.26e-06	0.000185	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—AKT1—melanoma	8.09e-06	0.000181	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—VEGFA—melanoma	7.66e-06	0.000171	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—STAT3—melanoma	7.59e-06	0.00017	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NRAS—melanoma	7.57e-06	0.000169	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PIK3CG—melanoma	7.5e-06	0.000168	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—VEGFA—melanoma	7.49e-06	0.000168	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—STAT3—melanoma	7.42e-06	0.000166	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NRAS—melanoma	7.4e-06	0.000165	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAPK3—melanoma	7.25e-06	0.000162	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPARG—melanoma	7.24e-06	0.000162	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAPK3—melanoma	7.09e-06	0.000158	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MYC—melanoma	7.05e-06	0.000158	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAPK1—melanoma	6.9e-06	0.000154	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MYC—melanoma	6.89e-06	0.000154	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EGFR—melanoma	6.89e-06	0.000154	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ABCB1—melanoma	6.81e-06	0.000152	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAPK1—melanoma	6.75e-06	0.000151	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EGFR—melanoma	6.74e-06	0.000151	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PIK3CD—melanoma	6.6e-06	0.000147	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—KRAS—melanoma	6.51e-06	0.000146	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALB—melanoma	6.51e-06	0.000146	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—KRAS—melanoma	6.37e-06	0.000142	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PRKCA—melanoma	6.26e-06	0.00014	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ERCC2—melanoma	6.21e-06	0.000139	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PIK3CA—melanoma	5.98e-06	0.000134	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PIK3CA—melanoma	5.85e-06	0.000131	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TP53—melanoma	5.79e-06	0.000129	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PIK3CB—melanoma	5.75e-06	0.000129	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PTGS2—melanoma	5.7e-06	0.000127	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TP53—melanoma	5.66e-06	0.000127	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HRAS—melanoma	5.54e-06	0.000124	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HRAS—melanoma	5.42e-06	0.000121	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL6—melanoma	5.3e-06	0.000118	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL6—melanoma	5.18e-06	0.000116	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PTEN—melanoma	4.97e-06	0.000111	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PIK3CG—melanoma	4.91e-06	0.00011	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AKT1—melanoma	4.89e-06	0.000109	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AKT1—melanoma	4.78e-06	0.000107	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPARG—melanoma	4.74e-06	0.000106	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PIK3CD—melanoma	4.31e-06	9.64e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALB—melanoma	4.26e-06	9.52e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PIK3CB—melanoma	3.76e-06	8.4e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PTGS2—melanoma	3.73e-06	8.33e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PIK3CA—melanoma	3.51e-06	7.84e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PTEN—melanoma	3.25e-06	7.26e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AKT1—melanoma	2.86e-06	6.4e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PIK3CA—melanoma	2.29e-06	5.12e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AKT1—melanoma	1.87e-06	4.19e-05	CbGpPWpGaD
